Neoadjuvant CAPEOX Versus Upfront Surgery for Locally Advanced Colon Cancer With Elevated CEA: A Single-Center, Open-Label, Randomized Controlled Trial
NA
The goal of this interventional clinical trial is to compare the efficacy o...
Detecting Minimal Residual Diseases (MRD) and Monitoring Clonal Evolution Using Ultrasensitive Chromosomal Aberrations Detection (UCAD) in Multiple Myeloma
N/A
The presence of minimal residual disease (MRD) is an important prognostic f...
Status
Unknown
Location
InsituteHBDH
Start Date
2023-05-01
Trial ID
NCT06302699
Feasibility Study to Evaluate Outpatient Blinatumomab in Subjects With Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia (ALL)
PHASE4
The study aims to determine the safety and feasibility of complete outpatie...